World's Best Scientists 2026 revealed!
VIEW LIST
Edward B. Garon

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 79 17331 16284 8684 8021 688 58075

Edward B. Garon publications per year

The chart shows the history of publications by Edward B. Garon between 1993 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Edward B. Garon published across 34 years, from 1993 to 2026, averaging 21.3 papers a year. Output peaked at 185 publications in 2023. 41 of the 724 publications appeared in the last two years.

No. of publications
50 100 150
Bar chart. Horizontal axis: year, 1993 to 2026. Vertical axis: number of publications, 0 to 185. Peak 185 publications in 2023. 1993: 1 publication 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 0 publications 1998: 0 publications 1999: 0 publications 2000: 0 publications 2001: 0 publications 2002: 0 publications 2003: 0 publications 2004: 0 publications 2005: 2 publications 2006: 1 publication 2007: 3 publications 2008: 2 publications 2009: 4 publications 2010: 14 publications 2011: 11 publications 2012: 15 publications 2013: 16 publications 2014: 26 publications 2015: 31 publications 2016: 30 publications 2017: 47 publications 2018: 47 publications 2019: 63 publications 2020: 48 publications 2021: 63 publications 2022: 45 publications 2023: 185 publications 2024: 29 publications 2025: 38 publications 2026: 3 publications
1993 2026

724 publications in total across all disciplines

View publications per year as a table
Edward B. Garon: publications per year, 1993 to 2026
Year Publications
1993 1
1994 0
1995 0
1996 0
1997 0
1998 0
1999 0
2000 0
2001 0
2002 0
2003 0
2004 0
2005 2
2006 1
2007 3
2008 2
2009 4
2010 14
2011 11
2012 15
2013 16
2014 26
2015 31
2016 30
2017 47
2018 47
2019 63
2020 48
2021 63
2022 45
2023 185
2024 29
2025 38
2026 3
Total 724
Download as CSV

Edward B. Garon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edward B. Garon sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 681–700 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 688 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336 688
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Edward B. Garon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edward B. Garon sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 78–79 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891 79
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Edward B. Garon is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on the field of Medicine, with specific emphasis on Oncology and Pulmonary and Respiratory Medicine. Other subfields of study include Cancer Research, Molecular Biology, and Immunology.

The scientist has contributed to topics such as:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Cancer Genomics and Diagnostics
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Immunotherapy and Immune Responses

Their recent published papers include:

  • Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer, 2020, Journal of Clinical Oncology
  • Capmatinib in MET Exon 14-Mutated or MET -Amplified Non-Small-Cell Lung Cancer, 2020, New England Journal of Medicine
  • Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer, 2020, JAMA Oncology
  • Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study, 2023, Journal of Clinical Oncology
  • Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189, 2021, Annals of Oncology

Frequent co-authors include:

  • Aaron Lisberg
  • Byoung Chul Cho
  • Melissa L. Johnson
  • Enriqueta Felip
  • Rebecca S. Heist

Key publication venues for their work are:

  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Cancer Research
  • Annals of Oncology
  • Regular and Young Investigator Award Abstracts

Best Publications

  • Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

    Naiyer A. Rizvi;Naiyer A. Rizvi;Matthew D. Hellmann;Matthew D. Hellmann;Alexandra Snyder;Alexandra Snyder;Pia Kvistborg

  • Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

    Roy S. Herbst;Paul Baas;Dong Wan Kim;Enriqueta Felip

  • Pembrolizumab for the treatment of non-small cell lung cancer

    Edward B. Garon;Naiyer A. Rizvi;Rina Hui;Natasha Leighl

  • Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

    Leena Gandhi;Delvys Rodríguez-Abreu;Shirish Gadgeel;Emilio Esteban

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

    Diego Chowell;Luc G. T. Morris;Claud M. Grigg;Jeffrey K. Weber

  • Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

    Edward B. Garon;Tudor Eliade Ciuleanu;Oscar Arrieta;Kumar Prabhash

  • Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

    Narek Shaverdian;Aaron E Lisberg;Krikor Bornazyan;Darlene Veruttipong

  • Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

    Shirish Gadgeel;Delvys Rodríguez-Abreu;Giovanna Speranza;Emilio Esteban

  • Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study

    Edward B. Garon;Matthew D. Hellmann;Naiyer A. Rizvi;Enric Carcereny

  • Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

    Lecia V. Sequist;Jean Charles Soria;Jonathan W. Goldman;Heather A. Wakelee

  • Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer

    Charles M. Rudin;Christine L. Hann;Edward B. Garon;Moacyr Ribeiro de Oliveira

  • Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

    Paul C. Tumeh;Matthew D. Hellmann;Omid Hamid;Katy K. Tsai

  • Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Kazuhiko Nakagawa;Edward B Garon;Takashi Seto;Makoto Nishio

  • Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial

    Naiyer A Rizvi;Byoung Chul Cho;Niels Reinmuth;Ki Hyeong Lee

  • A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

    A. Lisberg;A. Cummings;J.W. Goldman;K. Bornazyan

  • PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

    Jyoti D. Patel;Mark A. Socinski;Edward B. Garon;Craig H. Reynolds

  • Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC).

    M. G. Kris;B. E. Johnson;D. J. Kwiatkowski;A. J. Iafrate

  • Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.

    D. Rodríguez-Abreu;S.F. Powell;M.J. Hochmair;S. Gadgeel

  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

    K. Hastings;H.A. Yu;H.A. Yu;W. Wei;F. Sanchez-Vega

Frequent Co-Authors

Martin Reck
Martin Reck LungenClinic Grosshansdorf
Enriqueta Felip
Enriqueta Felip Vall d'Hebron Institut de Recerca
Steven M. Dubinett
Steven M. Dubinett University of California, Los Angeles
Roy S. Herbst
Roy S. Herbst Yale University
David R. Spigel
David R. Spigel Sarah Cannon Research Institute
Luis Paz-Ares
Luis Paz-Ares Complutense University of Madrid
Kazuhiko Nakagawa
Kazuhiko Nakagawa Kindai University
Myung-Ju Ahn
Myung-Ju Ahn Sungkyunkwan University
Matthew D. Hellmann
Matthew D. Hellmann Memorial Sloan Kettering Cancer Center
David Elashoff
David Elashoff University of California, Los Angeles

External Links

Personal website of Edward B. Garon

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA doesn’t always mean following the traditional path to an MD. There are flexible online degree options that offer specialized career opportunities and advanced credentials for healthcare professionals. For instance, registered nurses can take the next step with rn to np programs online, streamlining their journey to become nurse practitioners without putting their careers on hold.

Those interested in wellness and patient nutrition can consider earning a bachelor's in nutrition online. This credential opens doors to roles in public health, clinical settings, and community outreach.

Aspiring healthcare leaders might look to cahme-accredited online mha programs, giving graduates an edge in hospital or health system management. Meanwhile, practicing RNs seeking to advance without additional on-site requirements will find value in online rn to bsn programs no clinicals, combining flexibility and professional growth.

Each pathway supports a vital role in the evolving healthcare system, empowering students to pursue meaningful careers online.

Best Scientists Citing Edward B. Garon

Matthew D. Hellmann

Matthew D. Hellmann

Memorial Sloan Kettering Cancer Center

Publications: 126

Benjamin Besse

Benjamin Besse

University of Paris-Saclay

Publications: 122

Caicun Zhou

Caicun Zhou

Tongji University

Publications: 91

Martin Reck

Martin Reck

LungenClinic Grosshansdorf

Publications: 91

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

Publications: 90

Jedd D. Wolchok

Jedd D. Wolchok

Cornell University

Publications: 85

Mark G. Kris

Mark G. Kris

Memorial Sloan Kettering Cancer Center

Publications: 77

Charles M. Rudin

Charles M. Rudin

Memorial Sloan Kettering Cancer Center

Publications: 76

Fabrice Barlesi

Fabrice Barlesi

Institut Gustave Roussy

Publications: 74

Fred R. Hirsch

Fred R. Hirsch

Mount Sinai Hospital

Publications: 74

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 74

Charles Swanton

Charles Swanton

The Francis Crick Institute

Publications: 72

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 71

Luis Paz-Ares

Luis Paz-Ares

Complutense University of Madrid

Publications: 70

Li Zhang

Li Zhang

Sun Yat-sen University

Publications: 70

Enriqueta Felip

Enriqueta Felip

Vall d'Hebron Institut de Recerca

Publications: 70

Trending Scientists

James Annis

James Annis

Fermilab

Christopher S. Kochanek

Christopher S. Kochanek

The Ohio State University

William J. Steinbach

William J. Steinbach

Duke University

Umberto Dianzani

Umberto Dianzani

University of Eastern Piedmont Amadeo Avogadro

Thomas S. Kilduff

Thomas S. Kilduff

SRI International

Rashmi Kothary

Rashmi Kothary

Ottawa Hospital

Ian R. Sanders

Ian R. Sanders

University of Lausanne

Aleksander S. Popel

Aleksander S. Popel

Johns Hopkins University

Alyosha Molnar

Alyosha Molnar

Cornell University

Norbert Hoffmann

Norbert Hoffmann

Hamburg University of Technology

Tiffany Barnes

Tiffany Barnes

North Carolina State University

Tapani Vuorinen

Tapani Vuorinen

Aalto University

Karin Ingold

Karin Ingold

University of Bern

Antonino Carbone

Antonino Carbone

Centro di Riferimento Oncologico

Matej Brešar

Matej Brešar

University of Ljubljana

Katrin Linse

Katrin Linse

British Antarctic Survey

Related Medicine Rankings & Guides

2027 Best Online Nursing Programs in California: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in California: Accredited RN to BSN Programs
2027 Fastest Online MSN in Nursing Education Programs

2027 Fastest Online MSN in Nursing Education Programs
2027 Most Affordable CNA to RN Online Bridge Programs

2027 Most Affordable CNA to RN Online Bridge Programs
2027 Best Occupational Therapy Programs

2027 Best Occupational Therapy Programs
2027 Fastest Online Medical Assistant Associate Degree Programs

2027 Fastest Online Medical Assistant Associate Degree Programs
2027 Best Pathways to Pursue MSN without a BSN Degree

2027 Best Pathways to Pursue MSN without a BSN Degree
2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus
2027 Most Affordable LPN/LVN to BSN Online Bridge Programs

2027 Most Affordable LPN/LVN to BSN Online Bridge Programs
2027 Is Nursing School Worth It?

2027 Is Nursing School Worth It?
2027 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities

2027 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities
2027 Most Affordable Online BSN to MSN Bridge Programs

2027 Most Affordable Online BSN to MSN Bridge Programs
September 2027 Best Online Doctorate in Healthcare Management Programs

September 2027 Best Online Doctorate in Healthcare Management Programs
2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate

2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate
2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Best Second-Degree BSN Programs

2027 Best Second-Degree BSN Programs
2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus
2027 Most Affordable Online Medical Assistant Programs

2027 Most Affordable Online Medical Assistant Programs
2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs
2027 Fastest Online MSN in Health/Nursing Informatics Programs

2027 Fastest Online MSN in Health/Nursing Informatics Programs
2027 Most Affordable Online Dental Assistant to Dental Hygienist Bridge Programs

2027 Most Affordable Online Dental Assistant to Dental Hygienist Bridge Programs
2027 Best Shortest Online DNP Programs

2027 Best Shortest Online DNP Programs

Recently Published Articles

2027 Last-Minute Admissions: Online Health Sciences Degree Master's Programs Still Accepting Students

2027 Last-Minute Admissions: Online Health Sciences Degree Master's Programs Still Accepting Students
2027 Online Medical Assisting Degree Programs Costs: Tuition & Fees

2027 Online Medical Assisting Degree Programs Costs: Tuition & Fees
2027 Is Demand for Business Development Degree Graduates Growing or Declining?

2027 Is Demand for Business Development Degree Graduates Growing or Declining?
2027 How to Become a Substitute Teacher in Massachusetts

2027 How to Become a Substitute Teacher in Massachusetts
2027 Substitute Teaching License & Requirements in Virginia

2027 Substitute Teaching License & Requirements in Virginia
2027 Top Career Paths for AGACNPs

2027 Top Career Paths for AGACNPs
2027 Easy-Admission Online MSW Programs: What to Know Before Applying

2027 Easy-Admission Online MSW Programs: What to Know Before Applying
2027 Fastest-Growing Careers for Fine Arts Degree Graduates

2027 Fastest-Growing Careers for Fine Arts Degree Graduates
2027 AI, Automation, and the Future of School Counseling Degree Careers

2027 AI, Automation, and the Future of School Counseling Degree Careers
2027 Which Employers Hire Entertainment Business Degree Graduates? Industries, Roles, and Hiring Patterns

2027 Which Employers Hire Entertainment Business Degree Graduates? Industries, Roles, and Hiring Patterns
2027 Application Deadlines for Online Public Administration Master's Programs: Fall, Spring & Rolling Admissions

2027 Application Deadlines for Online Public Administration Master's Programs: Fall, Spring & Rolling Admissions
2027 Online MBA Admissions Timeline: When to Apply

2027 Online MBA Admissions Timeline: When to Apply
2027 Online Mathematics Bachelor's Degrees for Veterans and Military Students

2027 Online Mathematics Bachelor's Degrees for Veterans and Military Students
2027 Easiest Online Special Education Master's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions

2027 Easiest Online Special Education Master's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions
2027 Cheapest Accredited Online Mathematics Degree Programs: Tuition, Fees, and Financial Aid

2027 Cheapest Accredited Online Mathematics Degree Programs: Tuition, Fees, and Financial Aid
2027 How to Become a Nurse Practitioner in Alabama

2027 How to Become a Nurse Practitioner in Alabama
2027 Fastest Executive MHA (Master’s in Healthcare Administration) Programs

2027 Fastest Executive MHA (Master’s in Healthcare Administration) Programs
2027 Geography Careers: Guide to Career Paths, Options & Salary

2027 Geography Careers: Guide to Career Paths, Options & Salary
2027 ABA Graduate Admissions Guide: What BCBA Programs Look For

2027 ABA Graduate Admissions Guide: What BCBA Programs Look For
2027 Online Applied Behavior Analysis Doctorate Programs for Licensed Professionals

2027 Online Applied Behavior Analysis Doctorate Programs for Licensed Professionals
2027 Special Education vs. Elementary Education Degree: Explaining the Difference

2027 Special Education vs. Elementary Education Degree: Explaining the Difference